CRL Annual Total Assets
$8.20 B
+$592.23 M+7.79%
30 December 2023
Summary:
As of January 20, 2025, CRL annual total assets is $8.20 billion, with the most recent change of +$592.23 million (+7.79%) on December 30, 2023. During the last 3 years, it has risen by +$2.70 billion (+49.25%). CRL annual total assets is now at all-time high.CRL Total Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CRL Quarterly Total Assets
$8.00 B
+$55.56 M+0.70%
28 September 2024
Summary:
As of January 20, 2025, CRL quarterly total assets is $8.00 billion, with the most recent change of +$55.56 million (+0.70%) on September 28, 2024. Over the past year, it has dropped by -$191.16 million (-2.33%). CRL quarterly total assets is now -2.33% below its all-time high of $8.20 billion, reached on December 30, 2023.CRL Quarterly Total Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CRL Total Assets Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +7.8% | -2.3% |
| 3 y3 years | +49.3% | -2.3% |
| 5 y5 years | +112.5% | -2.3% |
CRL Total Assets High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +16.7% | -2.3% | +13.9% |
| 5 y | 5-year | at high | +74.6% | -2.3% | +70.6% |
| alltime | all time | at high | +3398.3% | -2.3% | +1906.5% |
Charles River Laboratories International Total Assets History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $8.00 B(+0.7%) |
| June 2024 | - | $7.95 B(-2.5%) |
| Mar 2024 | - | $8.15 B(-0.5%) |
| Dec 2023 | $8.20 B(+7.8%) | $8.20 B(+7.7%) |
| Sept 2023 | - | $7.61 B(-2.1%) |
| June 2023 | - | $7.77 B(+0.9%) |
| Mar 2023 | - | $7.70 B(+1.3%) |
| Dec 2022 | $7.60 B(+8.2%) | $7.60 B(+3.0%) |
| Sept 2022 | - | $7.38 B(-1.9%) |
| June 2022 | - | $7.53 B(+6.4%) |
| Mar 2022 | - | $7.08 B(+0.7%) |
| Dec 2021 | $7.02 B(+27.9%) | $7.02 B(-0.5%) |
| Sept 2021 | - | $7.06 B(+5.0%) |
| June 2021 | - | $6.72 B(+15.7%) |
| Mar 2021 | - | $5.81 B(+5.8%) |
| Dec 2020 | $5.49 B(+17.0%) | $5.49 B(+5.3%) |
| Sept 2020 | - | $5.21 B(-0.5%) |
| June 2020 | - | $5.24 B(+0.8%) |
| Mar 2020 | - | $5.20 B(+10.8%) |
| Dec 2019 | $4.69 B(+21.7%) | $4.69 B(+2.4%) |
| Sept 2019 | - | $4.58 B(-0.9%) |
| June 2019 | - | $4.63 B(+17.8%) |
| Mar 2019 | - | $3.93 B(+1.8%) |
| Dec 2018 | $3.86 B(+31.6%) | $3.86 B(+1.6%) |
| Sept 2018 | - | $3.80 B(-1.8%) |
| June 2018 | - | $3.87 B(+28.8%) |
| Mar 2018 | - | $3.00 B(+2.4%) |
| Dec 2017 | $2.93 B(+8.0%) | $2.93 B(+2.2%) |
| Sept 2017 | - | $2.87 B(+3.3%) |
| June 2017 | - | $2.77 B(+2.8%) |
| Mar 2017 | - | $2.70 B(-0.5%) |
| Dec 2016 | $2.71 B(+31.1%) | $2.71 B(+0.8%) |
| Sept 2016 | - | $2.69 B(-2.6%) |
| June 2016 | - | $2.76 B(+31.3%) |
| Mar 2016 | - | $2.10 B(+1.7%) |
| Dec 2015 | $2.07 B(+10.6%) | $2.07 B(+1.8%) |
| Sept 2015 | - | $2.03 B(+7.8%) |
| June 2015 | - | $1.89 B(+2.1%) |
| Mar 2015 | - | $1.85 B(-1.2%) |
| Dec 2014 | $1.87 B(+14.6%) | $1.87 B(+1.5%) |
| Sept 2014 | - | $1.84 B(-1.1%) |
| June 2014 | - | $1.86 B(+12.8%) |
| Mar 2014 | - | $1.65 B(+1.2%) |
| Dec 2013 | $1.63 B(+2.9%) | $1.63 B(-0.7%) |
| Sept 2013 | - | $1.64 B(+1.4%) |
| June 2013 | - | $1.62 B(+1.1%) |
| Mar 2013 | - | $1.60 B(+1.1%) |
| Dec 2012 | $1.59 B | $1.59 B(+1.2%) |
| Sept 2012 | - | $1.57 B(+1.4%) |
| June 2012 | - | $1.55 B(-0.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2012 | - | $1.56 B(-0.2%) |
| Dec 2011 | $1.56 B(-10.1%) | $1.56 B(-1.7%) |
| Sept 2011 | - | $1.59 B(-7.0%) |
| June 2011 | - | $1.71 B(-2.2%) |
| Mar 2011 | - | $1.74 B(+0.6%) |
| Dec 2010 | $1.73 B(-21.4%) | $1.73 B(-16.7%) |
| Sept 2010 | - | $2.08 B(-3.5%) |
| June 2010 | - | $2.16 B(-1.4%) |
| Mar 2010 | - | $2.19 B(-0.8%) |
| Dec 2009 | $2.20 B(+2.0%) | $2.20 B(+0.6%) |
| Sept 2009 | - | $2.19 B(+1.8%) |
| June 2009 | - | $2.15 B(+3.2%) |
| Mar 2009 | - | $2.09 B(-3.3%) |
| Dec 2008 | $2.16 B(-23.0%) | $2.16 B(-25.4%) |
| Sept 2008 | - | $2.90 B(+0.2%) |
| June 2008 | - | $2.89 B(+1.6%) |
| Mar 2008 | - | $2.84 B(+1.4%) |
| Dec 2007 | $2.81 B(+9.7%) | $2.81 B(+2.6%) |
| Sept 2007 | - | $2.74 B(+2.7%) |
| June 2007 | - | $2.66 B(+3.7%) |
| Mar 2007 | - | $2.57 B(+0.4%) |
| Dec 2006 | $2.56 B(+0.8%) | $2.56 B(+2.2%) |
| Sept 2006 | - | $2.50 B(-4.4%) |
| June 2006 | - | $2.62 B(+8.6%) |
| Mar 2006 | - | $2.41 B(-5.0%) |
| Dec 2005 | $2.54 B(-3.4%) | $2.54 B(-2.0%) |
| Sept 2005 | - | $2.59 B(+1.6%) |
| June 2005 | - | $2.55 B(-3.0%) |
| Mar 2005 | - | $2.63 B(+0.0%) |
| Dec 2004 | $2.63 B(+228.5%) | $2.63 B(+189.6%) |
| Sept 2004 | - | $907.05 M(+5.2%) |
| June 2004 | - | $862.38 M(+4.4%) |
| Mar 2004 | - | $825.83 M(+3.3%) |
| Dec 2003 | $799.55 M(+14.0%) | $799.55 M(+4.5%) |
| Sept 2003 | - | $765.15 M(+3.8%) |
| June 2003 | - | $737.07 M(+4.4%) |
| Mar 2003 | - | $706.14 M(+0.7%) |
| Dec 2002 | $701.34 M(+22.7%) | $701.34 M(+6.9%) |
| Sept 2002 | - | $656.31 M(+4.2%) |
| June 2002 | - | $629.88 M(-5.2%) |
| Mar 2002 | - | $664.19 M(+16.2%) |
| Dec 2001 | $571.36 M(+38.2%) | $571.36 M(-2.5%) |
| Sept 2001 | - | $586.07 M(+13.4%) |
| June 2001 | - | $516.79 M(-6.9%) |
| Mar 2001 | - | $555.38 M(+34.3%) |
| Dec 2000 | $413.55 M(+13.9%) | $413.55 M(+1.1%) |
| Sept 2000 | - | $409.12 M(+2.6%) |
| June 2000 | - | $398.90 M(-0.7%) |
| Mar 2000 | - | $401.60 M |
| Dec 1999 | $363.06 M(+55.0%) | - |
| Dec 1998 | $234.25 M | - |
FAQ
- What is Charles River Laboratories International annual total assets?
- What is the all time high annual total assets for Charles River Laboratories International?
- What is Charles River Laboratories International annual total assets year-on-year change?
- What is Charles River Laboratories International quarterly total assets?
- What is the all time high quarterly total assets for Charles River Laboratories International?
- What is Charles River Laboratories International quarterly total assets year-on-year change?
What is Charles River Laboratories International annual total assets?
The current annual total assets of CRL is $8.20 B
What is the all time high annual total assets for Charles River Laboratories International?
Charles River Laboratories International all-time high annual total assets is $8.20 B
What is Charles River Laboratories International annual total assets year-on-year change?
Over the past year, CRL annual total assets has changed by +$592.23 M (+7.79%)
What is Charles River Laboratories International quarterly total assets?
The current quarterly total assets of CRL is $8.00 B
What is the all time high quarterly total assets for Charles River Laboratories International?
Charles River Laboratories International all-time high quarterly total assets is $8.20 B
What is Charles River Laboratories International quarterly total assets year-on-year change?
Over the past year, CRL quarterly total assets has changed by -$191.16 M (-2.33%)